The epigenetic landscape of hepatocellular carcinoma: from molecular mechanisms to early detection biomarkers and precision therapy.
Hepatocellular carcinoma (HCC) remains a leading cause of global cancer mortality due to late diagnosis, molecular heterogeneity, and therapeutic resistance. Emerging evidence highlights that epigenetic and epitranscriptomic dysregulations drive hepatocarcinogenesis by altering gene expression programs without changing...